Drug Trial Radar · NCT03253263
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
295
Actual
Start
May 9, 2019
Primary completion
Jul 31, 2026
Study completion Jan 21, 2028
Sponsor
- Lead sponsor
- OHB Neonatology Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 17, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 0 hours, up to 24 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.
Conditions
- Bronchopulmonary Dysplasia
- Chronic Lung Disease of Prematurity
- Intraventricular Hemorrhage
- Retinopathy of Prematurity (ROP)
Interventions
OHB-607Drug
Participants will receive intravenous infusion of OHB-607 from birth up to PMA 29 weeks + 6 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction in the incidence of severe Bronchopulmonary Dysplasia (BPD) at 36 weeks (±3 days) Postmenstrual Age (PMA), or death at or before 36 weeks PMA, whichever comes first as compared to the SNC group.Time frame: Baseline through 36 weeks postmenstrual age (PMA)
Locations
62 sites in 13 countries. Site status is shown where the registry gives one.
Arkansas Children's Hospital
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Children's Hospital of Orange County
California City, California
Cedars Sinai Medical Center
Los Angeles, California
US Davis
Sacramento, California
Jackson Memorial Hospital
Miami, Florida
Tampa General Hospital
Tampa, Florida
University of Illinois at Chicago
Chicago, Illinois
Riley Hospital for Children
Indianapolis, Indiana
Memorial Hospital of South Bend
South Bend, Indiana
University of Louisville Hospital
Louisville, Kentucky
Ochsner Baptist Medical Center
New Orleans, Louisiana
Tufts Medical Center
Boston, Massachusetts
Children's Minnesota - Children's Hospital and Clinics - St. Paul
Saint Paul, Minnesota
Children's Minnesota - Children's Hospital and Clinics
Saint Paul, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
University of Rochester
Rochester, New York
Maria Fareri Children's Hospital
Valhalla, New York
Oklahoma Children's Hospital - PIN
Oklahoma City, Oklahoma
Medical University of South Carolina Children Hospital
Charleston, South Carolina
Texas Children's Hospital
Houston, Texas
UT Health Science Center
San Antonio, Texas
UVA Children's Hospital
Charlottesville, Virginia
Virginia Commonwealth University - Children's Hospital of Richmond at VCU
Richmond, Virginia
Royal Women's Hospital
Parkville, Australia
Mater Misericordiae Limited
South Brisbane, Australia
Royal Hospital for Women
Randwick, New South Wales, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Sainte Justine Hospital
Montreal, Quebec, Canada
Oulun Yliopistollinen Sairaala
Oulu, Finland
Klinikum Nürnberg
Nuremberg, Germany
Universitatsklinikum Leipzig
Leipzig, Saxony, Germany
Cork University Maternity Hospital
Cork, Wilton, Ireland
Azienda Ospedaliero-Universitaria Careggi SOD Neonatologia e Terapia Intensiva Neonatale
Florence, Italy
Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e
Genova, Italy
Presidio Ospedaliero Di Treviso Ca' Foncello
Treviso, Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
Azienda Ospedaliera Di Padova
Padova, Veneto, Italy
Showa Medical University Hospital
Tokyo, Japan
National Center for Child Health and Development
Tokyo, Japan
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.